Abstract
Isolation and bioactive effects of the roots of Chaerophyllum bulbosum L. were firstly investigated herein. Enzyme (acetylcholinesterase, butyrylcholinesterase, urease, α-amylase, α-glucosidase, and tyrosinase) inhibitory effects of C.bulbosum root extracts were tested. Three known compounds, n-heptadecanyl eicosanoate (1), stigmasterol (2), and β-sitosterol-3-O-β-d-glucopyranoside (3) were isolated from C.bulbosum. Antioxidant and enzyme inhibitory effects of isolated compounds were investigated. The hexane extract (IC50: 349.58±0.06μg/mL) displayed a higher α-glucosidase inhibitory effect than the standard (IC50: 378.66±0.14μg/mL). The best inhibitory effect was found in compound 2 on AChE (46.40±0.31%), BChE (56.41±0.54%), and urease (92.47±0.11%); compound 1 on α-amylase (22.27±0.61%); and compound 3 on α-glucosidase (12.43±0.25%) and tyrosinase (19.00±0.16%). All isolated compounds showed moderate antioxidant effects in all assays. This study contributes to the therapeutic uses of Chaerophyllum roots and emphasizes the value of C.bulbosum species for the development of novel therapeutic agents.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Zeitschrift fur Naturforschung. C, Journal of biosciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.